Online citations, reference lists, and bibliographies.
← Back to Search

Population Pharmacokinetics In Veterinary Medicine: Potential Use For Therapeutic Drug Monitoring And Prediction Of Tissue Residues.

T. Martín-Jiménez, J. Riviere
Published 1998 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Population pharmacokinetics can be defined as a study of the basic features of drug disposition in a population, accounting for the influence of diverse pathophysiological factors on pharmacokinetics, and explicitly estimating the magnitude of the interindividual and intraindividual variability. It is used to identify subpopulations of individuals that may present with differences in drug kinetics or in kinetic/dynamic responses. Rooted in procedures used in engineering systems, population pharmacokinetics methods were conceived as a means to determine the pharmacokinetic profile in populations in which a sparse number of samples were obtained per individual, such as those in late stage human clinical trials. This is the situation commonly encountered in all aspects of veterinary medicine. The exploratory nature of this technique allows one to probe relationships between clinical factors (such as age, gender, renal function, etc.) and drug disposition and/or effect. Similarly, the utilization of these techniques in the clinical research phases of drug development optimize the determination of efficacy and safety of drugs. Given the observational nature of most studies published so far, statistical methods to validate the population models are necessary. Simulation studies may be conducted to explore data collection designs that maximize information yield with a minimum expenditure of resources. The breadth of this approach has allowed population studies to be more commonly employed in all areas of drug therapy and clinical research. Finally, in veterinary medicine, there is an additional field in which population studies are potentially ideally suited: the application of this methodology to the study of tissue drug depletion and drug residues in production animals, and the establishment of withdrawal times tailored to the clinical or production conditions of populations or individuals. Such application would provide a major step toward assuring a safe food supply under a wide variety of dose and off-label clinical uses. Population pharmacokinetics is an ideal method for generating data in support of the implementation of flexible labelling policies and extralabel drug use recently approved under AMDUCA (Animal Medicinal Drug Use Clarification Act. 21 CFR Part 530).
This paper references
10.5840/MONIST18966322
From Animal to Man.
J. Conte (1896)
10.2307/1907503
Linear Statistical Inference and its Applications
F. Graybill (1968)
10.1080/00401706.1976.10489395
Newton-Raphson and Related Algorithms for Maximum Likelihood Variance Component Estimation
R. Jennrich (1976)
10.1002/cpt1979263294
Forecasting individual pharmacokinetics
L. Sheiner (1979)
10.1016/0010-468X(79)90025-4
A program package for simulation and parameter estimation in pharmacokinetic systems.
D. Z. D'Argenio (1979)
10.2307/2684123
The NONMEM System
Stuart L. Beal (1980)
10.1080/01621459.1983.10477973
Estimating the Error Rate of a Prediction Rule: Improvement on Cross-Validation
B. Efron (1983)
10.3109/03602538409015066
Alternative approaches to estimation of population pharmacokinetic parameters: comparison with the nonlinear mixed-effect model.
J. Steimer (1984)
10.3109/03602538409015064
Population pharmacokinetic data and parameter estimation based on their first two statistical moments.
Stuart L. Beal (1984)
10.1093/BIOMET/73.3.645
A maximum likelihood estimation method for random coefficient regression models
A. Mallet (1986)
10.1097/00000542-198801000-00010
Evaluating the Accuracy of Using Population Pharmacokinetic Data to Predict Plasma Concentrations of Alfentanil
P. Maitre (1988)
10.1248/CPB.36.1914
Bayesian prediction of serum phenytoin concentration in a simulation study.
S. Higuchi (1988)
10.1111/J.1365-2125.1989.TB05431.X
Population pharmacokinetics of tobramycin.
L. Aarons (1989)
10.1128/AAC.34.6.1165
Application of a Bayesian method to monitor and adjust vancomycin dosage regimens
A. Hurst (1990)
10.1016/0163-7258(91)90054-P
Prostaglandin and thromboxane biosynthesis.
W. Smith (1991)
10.2307/1269417
Prediction error and its estimation for subset-selected models
E. Roecker (1991)
10.1038/clpt.1991.100
Gentamicin population pharmacokinetic models for low birth weight infants using a new nonparametric method
W. Dodge (1991)
10.1038/clpt.1991.103
Netilmicin in the neonate: Population pharmacokinetic analysis and dosing recommendations
K. Fattinger (1991)
10.1016/0096-3003(91)90077-Z
Nonparametric EM Algorithms for estimating prior distributions
A. Schumitzky (1991)
10.2165/00003088-199121060-00006
Individualising Gentamicin Dosage Regimens
R. Jelliffe (1991)
10.1038/clpt.1992.47
Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development
C. Peck (1992)
10.2165/00003088-199222060-00004
Bayesian Parameter Estimation and Population Pharmacokinetics
A. Thomson (1992)
10.2165/00003088-199223010-00005
Population Pharmacokinetics of Gentamicin
D. Kisor (1992)
10.1128/AAC.37.1.93
Comparison of population pharmacokinetic models for gentamicin in spinal cord-injured and able-bodied patients.
T. Gilman (1993)
10.1097/00007691-199310000-00005
Individualizing Drug Dosage Regimens: Roles of Population Pharmacokinetic and Dynamic Models, Bayesian Fitting, and Adaptive Control
R. Jelliffe (1993)
10.1093/BIOMET/80.3.475
The Nonlinear Mixed Effects Model with a Smooth Random Effects Density
M. Davidian (1993)
10.1038/clpt.1994.142
A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data
L. Sheiner (1994)
10.1016/0020-7101(94)90091-4
Adaptive control of drug dosage regimens: basic foundations, relevant issues, and clinical examples.
R. Jelliffe (1994)
10.1097/00000542-199401000-00018
The Pharmacokinetics of Propofol in Children Using Three Different Data Analysis Approaches
B. Kataria (1994)
10.2165/00003088-199630020-00001
The Use of Population Pharmacokinetics in Drug Development
S. Vožeh (1996)
10.1046/J.1365-2885.1997.00095.X
Interspecies allometric analysis of the comparative pharmacokinetics of 44 drugs across veterinary and laboratory animal species.
J. Riviere (1997)
10.1016/S0009-9236(97)90097-7
Population pharmacokinetics of intravenous caffeine in neonates with apnea of prematurity
T. C. Lee (1997)
10.1002/j.1552-4604.1997.tb04326.x
Stability and Performance of a Population Pharmacokinetic Model
E. Ette (1997)
Population pharmacokinetics of gentamicin in horses.
T. Martín-Jiménez (1998)



This paper is referenced by
10.1111/jvp.12895
A history of antimicrobial drugs in animals: Evolution and revolution.
P. Lees (2020)
10.1007/s00204-019-02464-z
Integration of Food Animal Residue Avoidance Databank (FARAD) empirical methods for drug withdrawal interval determination with a mechanistic population-based interactive physiologically based pharmacokinetic (iPBPK) modeling platform: example for flunixin meglumine administration
M. Li (2019)
10.1111/jvp.12473
Mathematical modeling and simulation in animal health. Part III: Using nonlinear mixed‐effects to characterize and quantify variability in drug pharmacokinetics
C. Bon (2018)
10.1093/toxsci/kfy067
Probabilistic Physiologically Based Pharmacokinetic Model for Penicillin G in Milk From Dairy Cows Following Intramammary or Intramuscular Administrations
M. Li (2018)
10.1111/jvp.12351
The present and future of withdrawal period calculations for milk in the European Union: focus on heterogeneous, nonmonotonic data
A. Chevance (2017)
10.1016/j.fct.2017.06.023
Development and application of a population physiologically based pharmacokinetic model for penicillin G in swine and cattle for food safety assessment.
M. Li (2017)
10.2460/javma.250.10.1131
Guide to FARAD resources: historical and future perspectives.
J. Riviere (2017)
10.1017/S095026881700084X
Models of antimicrobial pressure on intestinal bacteria of the treated host populations
V. Volkova (2017)
10.19052/mv.4393
Disposición de danofloxacina en plasma y en tejidos comestibles de pollos parrilleros
Carlos Errecalde Erlicher (2017)
10.1111/jvp.12311
Mathematical modeling and simulation in animal health - Part II: principles, methods, applications, and value of physiologically based pharmacokinetic modeling in veterinary medicine and food safety assessment.
Zhoumeng Lin (2016)
10.1002/dta.2006
Tools to evaluate pharmacokinetics data for establishing maximum residue limits for approved veterinary drugs: examples from JECFA's work.
P. Sandérs (2016)
10.1111/jvp.12278
Mathematical modeling and simulation in animal health. Part I: Moving beyond pharmacokinetics.
J. Riviere (2016)
10.1089/FPD.2016.2152
Exploring Post-Treatment Reversion of Antimicrobial Resistance in Enteric Bacteria of Food Animals as a Resistance Mitigation Strategy.
V. Volkova (2016)
PHARMACOKINETICS , BIOAVILABILITY AND TISSUE RESIDUES OF AMIKACIN IN BROILER CHICKENS
M. Aboubakr (2016)
10.1002/9781118872819.CH6
Population Pharmacokinetic Modeling to Predict Withdrawal Times
S. Mason (2014)
POPULATION PHARMACOKINETICS AND CLINICAL RESPONSE OF METOPROLOL IN SOUTH INDIAN HYPERTERNSIVE PATIENTS
N. R. Yellu (2014)
POPULATION PHARMACOKINETICS OF PIOGLITAZONE IN SOUTH INDIAN TYPE-II DIABETIC PATIENTS
N. R. Yellu (2014)
10.1155/2014/789353
A Population Pharmacokinetic Approach to Describe Cephalexin Disposition in Adult and Aged Dogs
A. Prados (2014)
5 0 POPULATION PHARMACOKINETICS OF ORAL CLOPIDOGREL IN SOUTH INDIAN CARDIOVASCULAR PATIENTS USING NONMEM
M. Vattipalli (2014)
10.4315/0362-028X.JFP-13-199
Tetracycline residues in porcine stomach after administration via drinking water on a swine farm.
D. Lindquist (2014)
10.1128/AAC.02806-14
Interspecies Mixed-Effect Pharmacokinetic Modeling of Penicillin G in Cattle and Swine
M. Li (2014)
10.1111/j.1365-2885.2012.01420.x
Use of population pharmacokinetic modeling and Monte Carlo simulation to capture individual animal variability in the prediction of flunixin withdrawal times in cattle.
H Wu (2013)
10.1111/jvp.12041
Veterinary pharmacology: history, current status and future prospects.
P. Lees (2013)
10.1111/jvp.12026
Population pharmacokinetics of cefquinome in pigs.
D. Zhao (2013)
Aspects of the pharmacokinetics and pharmacodynamics of chloramphenicol, enrofloxacin and fluconazole in koalas (Phascolarctos cinereus)
L. A. Black (2013)
10.1111/j.1365-2885.2011.01327.x
Tissue/fluid correlation study for the depletion of sulfadimethoxine in bovine kidney, liver, plasma, urine, and oral fluid.
O. A. Chiesa (2012)
10.1533/9780857095794.3.469
Chemical Contamination of Poultry Meat and Eggs
I. Reyes-Herrera (2012)
Analysis Of Tetracycline Residues In Poultry And The Impact Of Its Wash - Off On Macrobrachium Rosenbergii Bijargi
Bijargi Shriharsh Rameshwar (2012)
10.20506/RST.31.1.2106
Use of antimicrobial agents in livestock.
S. Pagel (2012)
10.2460/AJVR.73.10.1641
Evaluation of factors important in modeling plasma concentrations of tetracycline hydrochloride administered in water in swine.
S. Mason (2012)
10.5772/33787
Pharmacokinetics of Antimicrobials in Food Producing Animals
S. Bhavsar (2012)
10.1002/9780470959916.CH16
Population Pharmacokinetic Models
Jason T Chittenden (2011)
See more
Semantic Scholar Logo Some data provided by SemanticScholar